Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 2015

View Archived Issues

Activation of engram cells by positive memories may suppress depression-related behaviors

Apceth and University of Cologne to develop cellular immunotherapies for cancer

Eligo Bioscience's development of antibiotics supported by new investment

Toulouse University Cancer Institute and Pierre Fabre sign framework agreement in oncology

Cleveland BioLabs reports data from phase I study of CBLB-612

Allegro Ophthalmics reports topline data from phase II study of Luminate

C3 Jian completes second phase II study of C16G2

Preliminary data presented on safety, PK and PD of PF-0538062 for hemophilia

FDA approves Iressa for metastatic NSCLC with certain EGFR mutations

Clozapine is a potent antiplatelet agent

Ferring to collaborate with Intralytix on bacteriophage therapy for IBD

Roche discloses V1A receptor antagonists

Cav2.2 blockers developed at Gruenenthal

Sunshine Lake Pharma reports 5-HT6 antagonists

Bayer Schering Pharma discloses EP4 antagonists

Bayer Schering Pharma presents alpha2C-adrenoceptor antagonists

RaQualia begins first-in-human study of 5-HT2B antagonist RQ-00310941

Anacor discloses positive results from phase III trials of crisaborole in atopic dermatitis

Phase III ENSPIRIT trial of custirsen sodium continues following final interim futility analysis

Blueprint Medicines receives FDA clearance to start phase I trials of BLU-554 and BLU-285

New phase I study investigates cabozantinib in combination therapy for genitourinary tumors

Results of in vivo neuroblastoma study of anisina plus vincristine

ACT-246475 shows a wider therapeutic window than ticagrelor

Researchers develop an improved p21 reporter mouse model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
XPC-837 restores network dysfunction in Dravet syndrome models
BioWorld Science
Researchers from Xenon Pharmaceuticals Inc. described the preclinical efficacy of XPC-837 in models of Dravet syndrome, a severe developmental and epileptic...